POLR2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.632170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.663700E-02
Normal-vs-Stage2
1.569640E-01
Normal-vs-Stage3
5.790200E-02
Normal-vs-Stage4
6.899000E-01
Stage1-vs-Stage2
9.659200E-01
Stage1-vs-Stage3
1.904810E-01
Stage1-vs-Stage4
4.588000E-01
Stage2-vs-Stage3
2.615400E-01
Stage2-vs-Stage4
3.574800E-01
Stage3-vs-Stage4
2.165400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.620360E-01
Normal-vs-AfricanAmerican
4.597200E-01
Normal-vs-Asian
9.920400E-02
Caucasian-vs-AfricanAmerican
3.817800E-01
Caucasian-vs-Asian
4.028800E-01
AfricanAmerican-vs-Asian
2.053400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.373360E-01
Normal-vs-Female
2.166600E-01
Male-vs-Female
2.085000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.040400E-01
Normal-vs-Age(41-60Yrs)
3.585000E-01
Normal-vs-Age(61-80Yrs)
1.320410E-01
Normal-vs-Age(81-100Yrs)
1.841980E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.079200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.943400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.671600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.088000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.854300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.214400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.191700E-02
Normal-vs-Daily Drinker
2.079600E-02
Normal-vs-Weekly Drinker
3.592200E-01
Normal-vs-Occasional Drinker
2.809800E-01
Normal-vs-Social Drinker
2.052000E-01
Non Drinker-vs-Daily Drinker
4.709200E-01
Non Drinker-vs-Weekly Drinker
5.935800E-01
Non Drinker-vs-Occasional Drinker
6.403600E-02
Non Drinker-vs-Social Drinker
1.543830E-01
Daily Drinker-vs-Weekly Drinker
3.734000E-01
Daily Drinker-vs-Occasional Drinker
2.354400E-02
Daily Drinker-vs-Social Drinker
6.091500E-02
Weekly Drinker-vs-Occasional Drinker
5.946200E-01
Weekly Drinker-vs-Social Drinker
7.527000E-01
Occasional Drinker-vs-Social Drinker
7.513000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.225200E-01
Normal-vs-Grade 2
8.222000E-01
Normal-vs-Grade 3
8.676200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.983400E-01
Grade 1-vs-Grade 3
3.404600E-01
Grade 1-vs-Grade 4
8.225200E-01
Grade 2-vs-Grade 3
1.780440E-01
Grade 2-vs-Grade 4
8.222000E-01
Grade 3-vs-Grade 4
8.676200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.187500E-02
Normal-vs-NonDiabetic
1.162830E-01
Diabetic-vs-NonDiabetic
1.062390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.083500E-02
Normal-vs-NoPancreatitis
9.996100E-02
Pancreatitis-vs-NoPancreatitis
8.660800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.616560E-01
Normal-vs-N1
1.844590E-01
N0-vs-N1
9.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.885600E-01
Normal-vs-TP53-NonMutant
2.843400E-01
TP53-Mutant-vs-TP53-NonMutant
1.784160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
